Journal profile · Cardiac & Cardiovascular Systems
Progress in Cardiovascular Diseases
ISSN 0033-0620 · eISSN 1873-1740 · W.B. Saunders Ltd · UNITED STATES · Bimonthly · Founded 1958
Progress in Cardiovascular Diseases: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 10.39; hybrid open access; APC about USD 4,130; median 66 days to acceptance (87 articles, last 24 months); community-reported acceptance: moderate; 152 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Progress in Cardiovascular Diseases is published by W.B. Saunders Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cardiac Imaging and Diagnostics, Cardiac electrophysiology and arrhythmias and Cardiovascular Function and Risk Factors, together about 23.9% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Progress in Cardiovascular Diseases covers the understanding and treatment of disorders of the heart and circulation. Issues are occasionally focused on a single topic. The journal publishes regular research articles and definitive reviews that capture the state of the art in the management of particular clinical problems in cardiology.
From the journal's Aims & Scope
Research area (LetPub): Cardiac & Cardiovascular Systems
Editor-in-chief Leandro SlipczukPublisher website
Editorial board by country: none in mainland China; most named United States 31, Argentina 4, Canada 3, Pakistan 2, Italy 1 (42 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cardiac Imaging and DiagnosticsMedicine8%
- Cardiac electrophysiology and arrhythmiasMedicine7.9%
- Cardiovascular Function and Risk FactorsMedicine7.9%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance6.9%
- Cardiac Valve Diseases and TreatmentsMedicine6.1%
- Cardiac Arrhythmias and TreatmentsMedicine5.4%
- Cardiac pacing and defibrillation studiesMedicine4.6%
- Human auditory perception and evaluationEngineering3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Cardiac & Cardiovascular Systems | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cardiac & Cardiovascular Systems | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 10.39LetPub ·
- Impact factor (publisher)
- 10.6Publisher website ·
- CiteScore 2026-06
- 13.6LetPub ·
- CiteScore (publisher)
- 13.6Publisher website ·
- SJR 2026-06
- 2.73LetPub ·
- SNIP 2026-06
- 2.54LetPub ·
- h-index
- 90LetPub ·
- h-index
- 183OpenAlex ·
- i10-index
- 2,174OpenAlex ·
- 2-year mean citedness
- 6.21OpenAlex ·
- Self-citation rate
- 4.7%LetPub ·
- Share of gold OA articles
- 24.45%LetPub ·
Volume
- Articles per year
- 85LetPub ·
Articles by year OpenAlex count · 3,683 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 85 | 22 | 80 |
| 2025 | 152 | 43 | 692 |
| 2024 | 125 | 44 | 1,475 |
| 2023 | 97 | 38 | 2,376 |
| 2022 | 120 | 38 | 1,829 |
| 2021 | 119 | 29 | 2,690 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
66 daysMedian, submission to acceptance · P25–P75 26 days – 92 days
- Acceptance to online
- median 3 days (87 articles)
- Submission to online
- median 69 days
- Sample
- 87 articles with submission and acceptance dates (227 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Submission to first decision
- 5 daysPublisher website ·
- First decision after review
- 31 daysPublisher website ·
- Submission to acceptance
- 4 daysPublisher website ·
- Acceptance to publication
- 3 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,130 / EUR 3,860 / GBP 3,310 / JPY 512,240 | — | — | |
| Publisher website | USD 4,290 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted12, with length limits
- editorialResearch Article: Original research articles are full length reports that cover topics relevant to the understanding and treatment of disorders of the heart and…main text ≤ 1,200 words
- editorialsEditorials: Invited only.Length not stated
- letterResearch Article: Original research articles are full length reports that cover topics relevant to the understanding and treatment of disorders of the heart and…Length not stated
- meta-analysisResearch Article: Original research articles are full length reports that cover topics relevant to the understanding and treatment of disorders of the heart and…Length not stated
- original researchResearch Article: Original research articles are full length reports that cover topics relevant to the understanding and treatment of disorders of the heart and…main text ≤ 4,000 words
- original research articleResearch Article: Original research articles are full length reports that cover topics relevant to the understanding and treatment of disorders of the heart and…Length not stated
- research articleResearch Article: Original research articles are full length reports that cover topics relevant to the understanding and treatment of disorders of the heart and…Length not stated
- reviewResearch Article: Original research articles are full length reports that cover topics relevant to the understanding and treatment of disorders of the heart and…Length not stated
- review articleResearch Article: Original research articles are full length reports that cover topics relevant to the understanding and treatment of disorders of the heart and…main text ≤ 5,000 words
- systematic reviewResearch Article: Original research articles are full length reports that cover topics relevant to the understanding and treatment of disorders of the heart and…Length not stated
- viewpointResearch Article: Original research articles are full length reports that cover topics relevant to the understanding and treatment of disorders of the heart and…Length not stated
- viewpointsViewpoints: Viewpoints may focus on papers not published in Progress in Cardiovascular Diseases.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Publishing ethics policy. Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process. Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing policy. Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- W.B. Saunders Ltd
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1958
- ISSN
- 0033-0620
- Electronic ISSN
- 1873-1740
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Progress in Cardiovascular Diseases
What CAS zone is Progress in Cardiovascular Diseases in?
In the 2025 upgraded edition of the CAS Journal Ranking, Progress in Cardiovascular Diseases is in Zone 2 of Medicine, and in Zone 3 of the minor category Cardiac & Cardiovascular Systems. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Progress in Cardiovascular Diseases?
The latest impact factor listed by LetPub is 10.39; CiteScore 13.6, h-index 183.
How long does peer review take at Progress in Cardiovascular Diseases?
Based on the dates recorded on 87 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 66 days (interquartile range 26–92 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Progress in Cardiovascular Diseases based?
Of the 42 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (31), Argentina (4) and Canada (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Progress in Cardiovascular Diseases?
According to LetPub and DOAJ records, Progress in Cardiovascular Diseases is indexed in SCIE and Scopus.
Is Progress in Cardiovascular Diseases open access, and what is the APC?
Progress in Cardiovascular Diseases is a hybrid journal. For open-access publication: APC about USD 4,130.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .